Home
Brawn Biotech Ltd Quarterly Result
Brawn Biotech Ltd
NSE: BRAWNBIOTECH
Net Profit - Last Quarter
Brawn Biotech Ltd Quarterly Results Key Highlights
- The Revenue of Brawn Biotech Ltd is ₹ 0.12 crore as of Jun '23 a1# The ebitda of Brawn Biotech Ltd for the Jun '23 is ₹ -0.04 crore as compare to the ebitda of ₹ 0 crore.
- This represent the decline of -9.2233718E16%a1#The Net Profit of Brawn Biotech Ltd is ₹ -0.04 crore as of Jun '23 a1#.
Brawn Biotech Ltd Quarterly Results Analysis
Market Price of Brawn Biotech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 15 Dec 2025 | 20.51 |
| 12 Dec 2025 | 20 |
| 09 Dec 2025 | 20.99 |
| 08 Dec 2025 | 20.07 |
| 05 Dec 2025 | 19.12 |
| 04 Dec 2025 | 20 |
| 03 Dec 2025 | 19.22 |
| 01 Dec 2025 | 19.26 |
| 28 Nov 2025 | 20.26 |
| 27 Nov 2025 | 20.75 |
Brawn Biotech Ltd
NSE: BRAWNBIOTECH
TOTALINCOME
EBITDA
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
EBITDA
Brawn Biotech Ltd
NSE: BRAWNBIOTECH
NETPROFIT
Brawn Biotech Ltd News Hub
Brawn Biotech reports standalone net loss of Rs 0.53 crore in the June 2024 quarter
Net Loss of Brawn Biotech reported to Rs 0.53 crore in the quarter ended June 2024 as against net lo
Read more
14 Aug 24
Brawn Biotech to discuss results
Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024. Powere
Read more
12 Aug 24
Brawn Biotech to conduct AGM
Brawn Biotech announced that the 39th Annual General Meeting (AGM) of the company will be held on 30
Read more
05 Sept 24
Brawn Biotech to conduct board meeting
Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024 Power
Read more
11 Nov 24
